Elevated preconception CD56 +16 + and/or Th1:Th2 levels predict benefit from IVIG therapy in subfertile women undergoing IVF

American Journal of Reproductive Immunology

Volumn 66, Issue 5, 2011, Pages 394-403

  Winger, Edward E ^a   Reed, Jane L ^a   Ashoush, Sherif ^b   El Toukhy, Tarek ^b   Ahuja, Sapna ^b   Taranissi, Mohamed ^b  

^a Laboratory for Reproductive Medicine and Immunology   (United States)

^b Assisted Reproduction and Gynaecology Centre   (United Kingdom)

Author keywords

IFN ; Immunotherapy; IVIG; Natural killer cell; Pregnancy; TNF

Indexed keywords

DEXAMETHASONE; ENOXAPARIN; IMMUNOGLOBULIN; INTERLEUKIN 10; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BIRTH RATE; BLOOD EXAMINATION; CD16+ T LYMPHOCYTE; CD56+ T LYMPHOCYTE; CORTICOSTEROID THERAPY; EMBRYO; EMBRYO TRANSFER; FEMALE; FEMALE SUBFERTILITY; FERTILIZATION IN VITRO; FETUS HEART RATE; GESTATIONAL SAC; HUMAN; IN VITRO STUDY; LIVE BIRTH; MAJOR CLINICAL STUDY; MATERNAL CARE; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PREGNANCY RATE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ADULT; ANTIGENS, CD56; CYTOKINES; EMBRYO IMPLANTATION; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFERTILITY; LIVE BIRTH; PRECONCEPTION CARE; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY RATE; TH1 CELLS; TH2 CELLS; TREATMENT OUTCOME;

EID: 80051944865     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2011.01018.x     Document Type: Article

References (47)

1. Coulam CB, Krysa LW, Bustillo M: Intravenous immunoglobulin for in-vitro fertilization failure. Hum Reprod 1994; 9:2265-2269.
2. Scher J, Salazar C: Clinical experience with IVIg Rx in patients with prior failed IVF pregnancies: report of 30 consecutive patients. Am J Reprod Immunol 2000; 44:121-124.
3. Mosmann TR, Sad S: The expanding universe of T cell subsets-Th1, Th2 and more. Immunol Today 1996; 17:138-146.
4. Lin H, Mossmann TR, Guilbert L, Tuntipopat L, Wegmann TG: Synthesis of T Helper -2 cytokines at the maternal fetal interface. J Immunol 1993; 151:4568.
5. Raghupathy R, Makhseed M, Azizieh F, Hassan N, Al-Azemi N, Al-Shamali E: Maternal Th1- and Th2-type reactivity to placental antigens in normal human pregnancy and unexplained recurrent spontaneous abortions. Cell Immunol 1999; 196:122-130.
6. Kwak-Kim JY, Chung-Bang HS, Ng SC, Ntrivalas EI, Mangubat CP, Beaman KD, Beer AE, Gilman-Sachs A: Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Hum Reprod 2003; 18:767-773.
7. Ng SC, Gilman-Sachs A, Thaker P, Beaman KD, Beer AE, Kwak-Kim J: Expression of intracellular Th1 and Th2 cytokines in women with recurrent spontaneous abortion, implantation failures after IVF/ET or normal pregnancy. Am J Reprod Immunol 2002; 48:77-86.
8. Thum MY: The relationship of systemic TNF-alpha and IFN-gamma with IVF treatment outcome and peripheral blood NK cells. Am J Reprod Immunol 2007; 57:210-217.
9. Coulam CB, Goodman C, Roussev RG, Thomasen EJ, Beaman KD: Systemic CD56+ cells can predict pregnancy outcome. Am J Reprod Immunol 1995; 33:40-46.
10. Beer AE, Kwak JY, Ruiz JE: Immunophenotypic profiles of peripheral blood lymphocytes in women with recurrent pregnancy losses and in infertile women with multiple failed in vitro fertilization cycles. Am J Reprod Immunol 1996; 35:376-382.
11. Kwak JY, Beaman KD, Gilman-Sachs A, Ruiz JE, Schewitz D, Beer AE: Up-regulated expression of CD56+, CD56+/CD16+, and CD19+ cells in peripheral blood lymphocytes in pregnant women with recurrent pregnancy losses. Am J Reprod Immunol 1995; 34:93-99.
12. Balasch J, Creus M, Fabregues F, Font J, Martorell J, Vanrell JA: Intravenous immunoglobulin preceding in vitro fertilization-embryo transfer for patients with repeated failure of embryo transfer. Fertil Steril 1996; 65:655-658.
13. Mangubat CP, Thaker PP, Cavalcante M, Kwak-Kim JYH, Beer AE: Etanercept and immune treatment in multiple IVF failures. ASRI XXI Annual Meeting, Chicago, June 9-12, 2001. Am J Reprod Immunol 2001; 45:345-346.
14. Winger EE, Reed JL, Ashoush S, Ahuja S, El-Toukhy T, Taranissi M: Treatment with Adalimumab (Humira®) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF. Am J Reprod Immunol 2009; 61:113-120.
15. Graphou O, Chioti A, Pantazi A, Tsukoura C, Kontopoulou V, Guorgiadou E, Balafoutas C, Koussoulakos S, Margaritis LH, Varla-Leftherioti M: Effect of intravenous immunoglobulin treatment on the Th1/Th2 balance in women with recurrent spontaneous abortions. Am J Reprod Immunol 2003; 49:21-29.
16. Yamada H, Morikawa M, Furuta I, Kato EH, Shimada S, Iwabuchi K, Minakami H: Intravenous immunoglobulin treatment in women with recurrent abortions: increased cytokine levels and reduced Th1/Th2 lymphocyte ratio in peripheral blood. Am J Reprod Immunol 2003; 49:84-89.
17. Kruse C, Varming K, Christiansen OB: Prospective, serial investigations of in-vitro lymphocyte cytokine production, CD62L expression and proliferative response to microbial antigens in women with recurrent miscarriage. Hum Reprod 2003; 18:2465-2472.
18. Clark DA, Coulam CB, Stricker RB: Is intravenous immunoglobulins (IVIG) efficacious in early pregnancy failure? A critical review and meta-analysis for patients who fail in vitro fertilization and embryo transfer (IVF). J Assist Reprod Genet 2006; 23: 1-13, Erratum: 2006;23:383.
19. Clark DA: Immunological factors in pregnancy wastage: fact or fiction. Am J Reprod Immunol 2008; 59:277-300.
20. Stricker RB, Steinleitner AS, Winger EE: Intravenous immunoglobulin (IVIG) therapy for immunologic abortion. Clin Appl Immunol Rev 2002; 2:187-199.
21. Stephenson MD, Fluker MR: Treatment of repeated unexplained in vitro fertilization failure with intravenous immunoglobulin: a randomized, placebo-controlled Canadian trial. Fertil Steril 2000; 74:1108-1113.
22. Van den Heuvel MJ, Peralta CG, Hatta K, Han VK, Clark DA: Decline in number of elevated blood CD3(+) CD56(+) NKT cells in response to intravenous immunoglobulin treatment correlates with successful pregnancy. Am J Reprod Immunol 2007; 58:447-459.
23. Esmon CT: The impact of the inflammatory response on coagulation. Thromb Res 2004; 114:321-327.
24. Nelson SM, Greer IA: The potential role of heparin in assisted conception. Hum Reprod Update 2008; 14:623-645. Epub 2008 Aug 12.
25. Allahbadia GN, Allahbadia SG: Low molecular weight heparin in immunological recurrent abortion - the incredible cure. J Assist Reprod Genet 2003; 20:82-90.
26. Girardi G: Complement inhibition keeps mothers calm and avoids fetal rejection. Immunol Invest 2008; 37:645-659.
27. Hills FA, Abrahams VM, Gonza′lez-Timo′n B, Francis J, Cloke B, Hinkson L, Rai R, Mor G, Regan L, Sullivan M, Lam EW, Brosens JJ: Heparin prevents programmed cell death in human trophoblast. Mol Hum Reprod 2006; 12:237-243.
28. Monien S, Kadecki O, Baumgarten S, Salama A, Dörner T, Kiesewetter H: Use of heparin in women with early and late miscarriages with and without thrombophilia. Clin Appl Thromb Hemost 2009; 15:636-644. Epub 2009 Aug 9.
29. Gilman-Sachs A, DuChateau BK, Aslakson CJ, Wohlgemuth GP, Kwak JY, Beer AE, Beaman KD: Natural Killer (NK) cell subsets and NK cell cytotoxicity in women with histories of recurrent spontaneous abortions. Am J Reprod Immunol 1999; 41:99-105.
30. Beer AE, Kwak JYH: Intravenous immunoglobulin G (IVIG) dream or reality? Presented at ART Symposium, Maui, HA, 1997.
31. Kwak JY, Gilman-Sachs A, Moretti M, Beaman KD, Beer AE: Natural killer cell cytotoxicity and paternal lymphocyte immunization in women with recurrent spontaneous abortions. Am J Reprod Immunol 1998; 40:352-358.
32. Geva E, Amit A, Lerner-Geva L, Yaron Y, Daniel Y, Schwartz T, Azem F, Yovel I, Lessing JB: Prednisone and aspirin improve pregnancy rate in patients with reproductive failure and autoimmune antibodies: a prospective study. Am J Reprod Immunol 2000; 43:36-40.
33. Hasegawa I, Yamanoto Y, Suzuki M, Murakawa H, Kurabayashi T, Takakuwa K, Tanaka K: Prednisolone plus low-dose aspirin improves the implantation rate in women with autoimmune conditions who are undergoing in vitro fertilization. Fertil Steril 1998; 70:1044-1048.
34. Vitale C, Chiossone L, Cantoni C, Morreale G, Cottalasso F, Moretti S, Pistorio A, Haupt R, Lanino E, Dini G, Moretta L, Mingari MC: The corticosteroid-induced inhibitory effect on NK cell function reflects down-regulation and/or dysfunction of triggering receptors involved in natural cytotoxicity. Eur J Immunol 2004; 34:3028-3038.
35. Rumste MM, Evers JL, Farquhar CM: ICSI versus conventional techniques for oocyte insemination during IVF in patients with non-male factor subfertility: a Cochrane review. Hum Reprod 2004; 19:223-227.
36. Winger EE, Reed JL, Ashoush S, Ahuja S, El-Toukhy T, Taranissi M: Degree of TNF-α/IL-10 cytokine elevation correlates with IVF success rates in women undergoing treatment with Adalimumab (Humira) and IVIG. Am J Reprod Immunol 2011; 65:610-618.
37. Ruiz JE, Kwak JY, Baum L, Gilman-Sachs A, Beaman KD, Kim YB, Beer AE: Intravenous immunoglobulin inhibits Natural Killer cell activity in vivo in women with recurrent spontaneous abortion. Am J Reprod Immunol 1996; 35:370-375.
38. Gorczynski RM, Hadidi S, Yu G, Clark DA: The same immunoregulatory molecules contribute to successful pregnancy and transplantation. Am J Reprod Immunol 2002; 47:1-9.
39. Winger EE, Reed JL: Low circulating CD4(+) CD25(+) Foxp3(+) T regulatory cell levels predict miscarriage risk in newly pregnant women with a history of failure. Am J Reprod Immunol 2011. doi:. [Epub ahead of print].
40. Clark DA, Wong K, Banwatt D, Chen Z, Liu J, Lee L, Gorczynski RM, Blajchman MA: CD200-dependent and nonCD200-dependent pathways of NK cell suppression by human IVIG. J Assist Reprod Genet 2008; 25:67-72.
41. Wright GJ, Cherwinski H, Foster-Cuevas M, Brooke G, Puklavec MJ, Bigler M, Song Y, Jenmalm M, Gorman D, McClanahan T, Liu M-R, Brown MH, Sedgewick JD, Phillips JH, Barclay AN: Characterization of the CD200 receptor family in mice and humans and their interaction with CD200. J Immunol 2003; 171:3034-3046.
42. Gorczynski RM, Chen Z, Clark DA, Yu K, Lee L, Nachman J, Wong S, Marsden P: Structural and functional heterogeneity in the CD200R family of immunoregulatory molecules at the feto-maternal interface. Am J Reprod Immunol 2004; 52:147-163.
43. Siragam V, Crow AR, Brinc D, Song S, Freedman J, Lazarus AH: Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells. Nat Med 2006; 12:688-692.
44. Austgulen R, Arntzen KJ, Vatten LJ, Kahn J, Sunde A: Detection of cytokines (interleukin-1, interleukin-6, transforming growth factor-beta) and soluble tumour necrosis factor receptors in embryo culture fluids during in-vitro fertilization. Hum Reprod 1995; 10:171-176.
45. Leisa J, Morrison LJ, Jennifer L, Marcinkiewicz JL: Tumor necrosis factor α enhances oocyte/follicle apoptosis in the neonatal rat ovary. Biol Reprod 2002; 66:450-457.
46. Cianci A, Calogero AE, Palumbo MA, Burrello N, Ciotta L, Palumbo G, Bernardini R: Relationship between tumour necrosis factor alpha and sex steroid concentrations in the follicular fluid of women with immunological infertility. Hum Reprod 1996; 11:265-268.
47. Stephenson MD, Kutteh WH, Purkiss S, Librach C, Schultz P, Houlihan E, Liao C: Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentered randomized placebo-controlled trial. Hum Reprod 2010; 25:2203-2209.